ES2013431A6 - Procedimiento para preparar peptidos de somatostatina. - Google Patents

Procedimiento para preparar peptidos de somatostatina.

Info

Publication number: ES2013431A6
Authority: ES; Spain
Prior art keywords: peptides; procedure; preparing; somatostatine; formula
Prior art date: 1988-04-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

ES8901255A

Other languages

English (en)

Spanish (es)

Inventor

Rainer Albert

Wilfried Bauer

Francois Cardinaux

Janos Pless

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sandoz AG

Original Assignee

Sandoz AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-04-11

Filing date

1989-04-11

Publication date

1990-05-01

1988-04-11 Priority claimed from GB888808442A external-priority patent/GB8808442D0/en

1988-11-11 Priority claimed from GB888826452A external-priority patent/GB8826452D0/en

1989-04-11 Application filed by Sandoz AG filed Critical Sandoz AG

1990-05-01 Publication of ES2013431A6 publication Critical patent/ES2013431A6/es

2009-04-11 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

238000000034 method Methods 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
108010056088 Somatostatin Proteins 0.000 abstract 3
102000005157 Somatostatin Human genes 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract 1
102000018997 Growth Hormone Human genes 0.000 abstract 1
108010051696 Growth Hormone Proteins 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000000122 growth hormone Substances 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Biophysics (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Psychiatry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

ES8901255A 1988-04-11 1989-04-11 Procedimiento para preparar peptidos de somatostatina. Expired - Lifetime ES2013431A6 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB888808442A GB8808442D0 (en)	1988-04-11	1988-04-11	Peptide derivatives
GB888826452A GB8826452D0 (en)	1988-11-11	1988-11-11	Peptide derivatives

Publications (1)

Publication Number	Publication Date
ES2013431A6 true ES2013431A6 (es)	1990-05-01

Family

ID=26293760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES8901255A Expired - Lifetime ES2013431A6 (es)	1988-04-11	1989-04-11	Procedimiento para preparar peptidos de somatostatina.

Country Status (14)

Country	Link
JP (1)	JPH01305098A (fr)
AU (1)	AU3263989A (fr)
BE (1)	BE1003200A4 (fr)
CH (1)	CH677795A5 (fr)
DE (1)	DE3910667A1 (fr)
DK (1)	DK171489A (fr)
ES (1)	ES2013431A6 (fr)
FR (1)	FR2629824B1 (fr)
GB (1)	GB2224280B (fr)
IL (1)	IL89897A0 (fr)
IT (1)	IT1231943B (fr)
LU (1)	LU87496A1 (fr)
NL (1)	NL8900882A (fr)
SE (1)	SE8901278L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1288224B1 (fr) *	1993-08-09	2008-06-25	Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S.	Derivées des peptides therapeutiques
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4139526A (en) *	1977-12-01	1979-02-13	Merck & Co., Inc.	Somatostatin analogs
HUT42101A (en) *	1985-01-07	1987-06-29	Sandoz Ag	Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
JPH085913B2 (ja) *	1985-09-12	1996-01-24	ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド	治療用ソマトスタチン同族体
HU206890B (en) *	1986-10-13	1993-01-28	Sandoz Ag	Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components

1989
- 1989-04-03 DE DE3910667A patent/DE3910667A1/de not_active Withdrawn
- 1989-04-07 LU LU87496A patent/LU87496A1/fr unknown
- 1989-04-07 CH CH1301/89A patent/CH677795A5/de not_active IP Right Cessation
- 1989-04-07 GB GB8907902A patent/GB2224280B/en not_active Expired - Lifetime
- 1989-04-10 BE BE8900400A patent/BE1003200A4/fr not_active IP Right Cessation
- 1989-04-10 JP JP1090507A patent/JPH01305098A/ja active Pending
- 1989-04-10 SE SE8901278A patent/SE8901278L/ not_active Application Discontinuation
- 1989-04-10 IT IT8947833A patent/IT1231943B/it active
- 1989-04-10 IL IL89897A patent/IL89897A0/xx unknown
- 1989-04-10 FR FR8904785A patent/FR2629824B1/fr not_active Expired - Fee Related
- 1989-04-10 NL NL8900882A patent/NL8900882A/nl not_active Application Discontinuation
- 1989-04-10 DK DK171489A patent/DK171489A/da active Protection Beyond IP Right Term
- 1989-04-10 AU AU32639/89A patent/AU3263989A/en not_active Abandoned
- 1989-04-11 ES ES8901255A patent/ES2013431A6/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CH677795A5 (fr)	1991-06-28
FR2629824A1 (fr)	1989-10-13
IT8947833A0 (it)	1989-04-10
AU3263989A (en)	1989-10-12
LU87496A1 (fr)	1989-11-14
SE8901278L (sv)	1989-10-12
IT1231943B (it)	1992-01-16
DK171489A (da)	1989-10-12
GB8907902D0 (en)	1989-05-24
SE8901278D0 (sv)	1989-04-10
GB2224280A (en)	1990-05-02
JPH01305098A (ja)	1989-12-08
GB2224280B (en)	1992-07-08
FR2629824B1 (fr)	1995-03-10
IL89897A0 (en)	1989-12-15
NL8900882A (nl)	1989-11-01
DK171489D0 (da)	1989-04-10
BE1003200A4 (fr)	1992-01-14
DE3910667A1 (de)	1989-10-19

Similar Documents

Publication	Publication Date	Title
MX9709278A (es)	1998-03-31	Dipeptidos que promueven la liberacion de la hormona de crecimiento, composiciones que los contienen y uso de los mismos.
DK126389D0 (da)	1989-03-15	Peptidforbindelser
FR2385688A1 (fr)	1978-10-27	Nouveaux peptides a activite biologique
RU94046306A (ru)	1996-10-27	Производные индолокарбазолимида, смесь их изомеров или отдельные изомеры и их соли и фармацевтическая композиция с активностью, ингибирующей протеинкиназу с или киназу легкой миозиновой цепи или подавляющей иммунные реакции
ES527542A0 (es)	1985-11-01	Un procedimiento para preparar nuevos peptidos
ES2015645A6 (es)	1990-09-01	Procedimiento de obtencion de un peptido de calcitonina o antagonista de la hormona liberadora de hormona luteinizante.
MY135057A (en)	2008-01-31	Dolastatin 15 derivatives
NO940299L (no)	1994-01-28	Peptid med organbeskyttende aktivitet
TW200517400A (en)	2005-06-01	Antagonistic analogs of GH-RH (2003)
ES2010283A6 (es)	1989-11-01	Procedimiento para preparar derivados de somatostatina.
BG105638A (en)	2002-01-31	Antagonist analogs of gh-rh inhibiting igf-i and -ii
ES2062137T3 (es)	1994-12-16	Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
MY104979A (en)	1994-07-30	[ 5(6)(ih-azole-1-ylmethyl) benzimidazole] carbamates.
AR004497A1 (es)	1998-12-16	Un análogo hexapéptido cíclico de somatostatina, procedimiento para prepararlos y las composiciones farmacéuticas que los contienen y el uso de dicho hexapéptido para la preparación de una composición farmacéutica.
ES553691A0 (es)	1987-08-01	Procedimiento para la obtencion de un peptido.
ZA916918B (en)	1993-03-01	Amino acid analogs as CCK antagonists.
AR044852A1 (es)	2005-10-05	Una composicion farmaceutica para la administracion parenteral que comprende un analogo de somatostatina
ES2112921T3 (es)	1998-04-16	Peptidos y anticuerpos para el tratamiento de la artritis reumatoide.
DE69619530D1 (de)	2002-04-04	Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
BG102514A (en)	1999-04-30	New lh-rh-antagonists of improved effect
ES2052801T3 (es)	1994-07-16	Procedimiento diastereoselectivo para la preparacion de intermediarios utiles para la sintesis de derivados peptidicos.
ES2065855B1 (es)	1995-09-01	Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
ATE224724T1 (de)	2002-10-15	Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin- rezeptor interaktion
ES2061679T3 (es)	1994-12-16	Un procedimiento para preparar un peptido.
ES2061958T3 (es)	1994-12-16	Nuevos analogos retro-inversos de timopentina, el metodo para su sintesis y su uso en la preparacion de composiciones farmaceuticas.

Legal Events

Date	Code	Title	Description
1992-01-01	SA6	Expiration date (snapshot 920101)	Free format text: 2009-04-11
2000-03-16	FD1A	Patent lapsed	Effective date: 20000201